Distinguishing Neurofibroma From Desmoplastic Melanoma: The Value of p53.

about

Distinguishing Neurofibroma From Desmoplastic Melanoma: The Value of p53.

Item

http://www.wikidata.org/entity/Q45942665

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Distinguishing Neurofibroma From Desmoplastic Melanoma: The Value of p53.

@en

Distinguishing Neurofibroma From Desmoplastic Melanoma: The Value of p53.

@nl

type

Item

label

Distinguishing Neurofibroma From Desmoplastic Melanoma: The Value of p53.

@en

Distinguishing Neurofibroma From Desmoplastic Melanoma: The Value of p53.

@nl

prefLabel

Distinguishing Neurofibroma From Desmoplastic Melanoma: The Value of p53.

@en

Distinguishing Neurofibroma From Desmoplastic Melanoma: The Value of p53.

@nl

P1476

Distinguishing Neurofibroma From Desmoplastic Melanoma: The Value of p53.

@en

P2093

Anna-Marie Hosking

http://www.w3.org/2001/XMLSchema#string

Ashley Elsensohn

http://www.w3.org/2001/XMLSchema#string

Jessica Shiu

http://www.w3.org/2001/XMLSchema#string

Narina Grove

http://www.w3.org/2001/XMLSchema#string

Ronald Barr

http://www.w3.org/2001/XMLSchema#string

Sébastien de Feraudy

http://www.w3.org/2001/XMLSchema#string

P2860

Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-alpha3 binding

Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway

NF1 Mutations Are Common in Desmoplastic Melanoma.

Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors.

Desmoplastic melanoma with sarcomatoid dedifferentiation.

Absence of V599E BRAF mutations in desmoplastic melanomas.

Distinguishing neurofibroma from desmoplastic melanoma: the value of the CD34 fingerprint.

P31

scholarly article

P356

10.1097/PAS.0000000000000978

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29112020

http://www.w3.org/2001/XMLSchema#string

P932

6095644

http://www.w3.org/2001/XMLSchema#string